Hamburg – CMS has advised Mayfair Beteiligungsfonds II on the IPO of Vapiano SE. As a major shareholder, Mayfair holds around 44% of the shares in Vapiano. A total of almost eight million shares at EUR 23 per share were placed with investors in the course of the flotation. The transaction value is thus EUR 184 million, of which Vapiano SE will receive around EUR 85 million. The company intends to use most of the funds to continue the international expansion of its business. Trading in the shares on the Prime Standard of Deutsche Börse is scheduled to start on 27 June.
A team headed by CMS partner Philipp Melzer advised Mayfair on all capital market aspects of the Vapiano IPO. The corporate law side was handled by CMS partners Dr Christian von Lenthe and Dr Jacob Siebert, who also advised Mayfair on its investment in the Vapiano Group in 2011.
CMS Hasche Sigle
Dr Christian von Lenthe, Client Relationship Partner
Dr Jacob Siebert, Partner
Dr Henrik Drinkuth, Partner
Dr Anja Wiedemann, Associate, all Corporate
Philipp Melzer, Partner
Jörg Baumgartner, Senior Associate, both Capital Markets
Dr Eckhard Schmid, Partner
Dr Daniel Ludwig, Partner, both Employment